GLP-1 receptor agonists show direct dermatological effects including potential benefits for inflammatory skin diseases, expanding their therapeutic profile beyond metabolism.
2014-2025 evidence reviewedDecade of literature shows GLP-1 drugs have direct effects on skin beyond their metabolic benefits
What the researchers found
GLP-1 RAs exert direct dermatological effects including potential benefits in inflammatory skin diseases, expanding their known therapeutic profile beyond metabolic applications.
Why it matters
With millions of people now taking GLP-1 drugs, understanding skin effects helps clinicians and patients anticipate dermatological changes and could open new treatment paths for skin diseases.
The numbers in context
51 studies met criteria. 34 reported adverse effects (hypersensitivity, injection-site reactions, pruritus, urticaria, angioedema, bullous pemphigoid). 17 reported beneficial outcomes (psoriasis, HS, wound healing).
How the study worked
Systematic review of EMBASE, PubMed, Web of Science, and Google Scholar from 2014-2025, including peer-reviewed human studies on GLP-1 RA dermatological effects.
Who was studied
Patients on GLP-1 RAs with dermatological effects
What this study cannot tell us
Heterogeneous studies with varying designs. Some skin effects may be related to weight loss rather than direct GLP-1 receptor activity in skin.
How to read the evidence
Systematic review of mostly observational studies and case reports. While methodologically sound, the underlying evidence is heterogeneous.
When this study was published
Published in 2025, providing the most comprehensive review of GLP-1 RA dermatological effects to date.
The bigger picture
GLP-1 receptors throughout the body continue to reveal new therapeutic possibilities. Dermatological effects add yet another dimension to these increasingly versatile medications.
Questions still open
- Which inflammatory skin diseases respond best to GLP-1 RA treatment?
- Are skin effects dose-dependent or specific to certain GLP-1 drugs?
Common questions
Can GLP-1 drugs affect your skin?
Could GLP-1 drugs help treat skin diseases like psoriasis?
Read the original research
A Closer Look at the Dermatological Profile of GLP-1 Agonists.
Diseases (Basel, Switzerland), 13(5)
Citation
Persson, Calista; Eaton, Allison; Mayrovitz, Harvey N. (2025). A Closer Look at the Dermatological Profile of GLP-1 Agonists.. Diseases (Basel, Switzerland), 13(5). https://doi.org/10.3390/diseases13050127